| Term 
 | Definition 
 
        | •	Drug metabolism can produce metabolites that may be more active, equipotent, less active, toxic or with altered therapeutic activity as compared to the parent compound •	 The type of metabolite generated is highly dependent on the chemical structure of the parent compound
 •	 The metabolites may play significant role in both pharmacodynamic and pharmacokinetic properties of the drug
 •	 DDIs involving metabolism should be carefully studied if there is production of active metabolites
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | o	Options: 	Half life = ~14 h -> Half life = 20-30h
 	10-40X more potent
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | o	The formation of oxidized analog is the primary inactivation pathway for 1,4-DHP type CCBs |  | 
        |  | 
        
        | Term 
 
        | Active à Inactive (Phase II) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Active à Altered activity |  | Definition 
 
        | o	Altered activity can refer to altered therapeutic activity or toxicity o	 Drug-induced hepatotoxicity is the most common type of toxicity seen with drugs
 o	 Hepatotoxicity is potentiated by underlying liver disorders, age and external inhibitors/inducers of microsomal enzymes
 o	 Other toxic reactions include; idiosyncratic reactions and drug/chemical induced carcinogenesis
 o	 The toxic reactions are primarily due to generation of electrophiles or free radical containing metabolites
 o	General electrophilic reaction seen as a result of metabolism
 o	General free radical type reaction
 o	Drug-induced chemical carcinogenesis
 |  | 
        |  |